Non-invasive urine-based diagnostic test for prostate cancer screening that analyzes PSA N-glycomic alterations using recombinant antibody technology. Reduces false positives, requires no specialized operator training, and provides risk stratification for clinical decision-making. Designed for cost-...
Manufactured by
iPASY Technologies Kft
Veszprém, Hungary
iPASy is revolutionizing prostate cancer screening with a urine-based, non-invasive diagnostic that detects disease-specific glycan patterns of urinary PSA, offering up to six-times higher specificity than blood-based tests. Our vision is to make prostate cancer detection accurate, accessible, and patient-friendly worldwide , with upcoming launches in Europe and the U.S. in collaboration with Mayo Clinic .
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Glycanostics, s.r.o.
Slovakia · 5 relevant products
Biomerica, Inc.
United States · 2 relevant products
Boditech Med Inc.
South Korea · 2 relevant products
75 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →18 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 101 closest product alternatives
Glycanostics, s.r.o. · Slovakia
Early-stage prostate cancer diagnostic test utilizing advanced glycan analysis for highly accurate detection. Designed to identify prostate cancer at initial stages, enabling timely clinical intervention and improved patient outcomes.
Biomerica, Inc. · United States
An advanced diagnostic test for prostate cancer screening. Designed as an at-home screening product targeting high-prevalence cancer detection.
Boditech Med Inc. · South Korea
A diagnostic test reagent for screening prostate cancer and monitoring the effects of treatment.
98 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products